Recent Articles and Case Updates:
Patent
As pharmaceutical companies spend more and more money developing new methods for treating and preventing medical problems, the law surrounding patentability of what may be referred to generally as “medical methods” becomes murkier and murkier.
Trademark
USPTO refuses to find fraud where trademark applicant relied on advice of counsel.
Copyright
Among the bundle of rights set forth in 17 U.S.C. § 106, copyright owners of certain works have the exclusive right to publicly perform the work.
Trade Secret
Traditionally, protecting a company’s trade secrets against misappropriation was generally considered to be primarily a matter of limiting access to confidential information, controlling the distribution of documents containing such information, monitoring the external dissemination of information regarding the company and its technology, and blocking access by outsiders to the company’s facilities.
IP Strategy, Due Diligence and Risk Assessment
China intellectual property protection: not too many years ago that would have been considered an oxymoron. Then the Chinese government announced its future economy would be based on innovation, not manufacturing.
Licensing
How do trademarks relate to the antitrust lawsuit filed by Tom Brady et al. against the National Football League (NFL), you ask?
Litigation and Dispute Resolution
Decision Tree Analysis facilitates complex decision-making. In addition to its use in commercial settings and economics departments, for example, “DTA” works well in the legal environment.
Case Law Update
The U.S. Supreme Court’s 6-2 decision in Golan v. Holder on January 18, 2012, confirmed that owners of certain copyrighted works authored outside of the United States can continue to enjoy restored protection under U.S. Copyright law, despite such works having been in the public domain prior to 1994.
Practice Management
Effective February 1, 2011, Jonathan H. Spadt, who has been with the firm since 1997, becomes the firm’s new CEO and President.
